Trinity Biotech (TRIB) Enterprise Value (2009 - 2025)

Trinity Biotech (TRIB) has reported Enterprise Value for 17 consecutive years, with -$5.1 million the latest figure, recorded in Q4 2025.

• Quarterly Enterprise Value rose 32.59% year-over-year to -$5.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$5.1 million (up 32.59% YoY) and the FY2025 annual result came in at -$5.1 million, up 32.59% from the prior year.
• Enterprise Value grew to -$5.1 million in Q4 2025 per TRIB's latest filing, from -$7.9 million in the prior quarter.
• Over the last five years, Enterprise Value for TRIB reached as high as -$2.8 million in Q3 2024 and fell as low as -$32.3 million in Q1 2021.
• A 5-year average of -$14.1 million and a median of -$9.0 million in 2022 frame the typical range for Enterprise Value.
• Annual changes were most pronounced in 2021 — Enterprise Value plunged 143.71% — and 2024, when it jumped 80.04%.
• Year by year, Enterprise Value stood at -$25.9 million in 2021, then jumped by 74.23% to -$6.7 million in 2022, then jumped by 41.73% to -$3.9 million in 2023, then tumbled by 95.89% to -$7.6 million in 2024, then jumped by 32.59% to -$5.1 million in 2025.
• According to Business Quant data, Enterprise Value over the past three periods registered -$5.1 million, -$7.9 million, and -$7.6 million for Q4 2025, Q2 2025, and Q4 2024 respectively.